Pathophysiology of lipid transport disorders.
Over the past decade considerable insight into the mechanisms involved in normal and abnormal transport as well as the mode of action of hypolipidaemic drugs has been achieved. This progress has made the approach to the hyperlipidaemic patient increasingly more precise and effective.
D000273:Adipose Tissue / Q000166:cytology; D001059:Apoproteins / Q000378:metabolism; D001692:Biological Transport; D002914:Chylomicrons / Q000097:blood; D006801:Humans; D006937:Hypercholesterolemia / Q000378:metabolism; D006949:Hyperlipidemias / Q000175:diagnosis / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D014280:Triglycerides / Q000097:blood
D001059:Apoproteins; D002914:Chylomicrons; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D014280:Triglycerides